RE:update from an german stock information lettergoogle translator: our absolute top pick in the biotech sector is as before Sirona Biochem (WKN: A0RM6R). last days to die trended share something weak, had them die well opened last chance yourself die Sirona shares as low place to the depot. Solo's reported for the current quarter Mega-licensing deal for the new skin whitening provides a lot of upside potential. Yesterday Sirona Biochem announced the start of one research cooperation Dr. Caigan you by the University of British Columbia MIT. It is about to die investigate the efficacy of new drug compounds Sirona Biochem to application in the preservation of red blood cells (RBC) and other cells. The aim is to storability of blood products die Significantly increase. Results Will place for the fourth quarter 2016 expected. increases Analysts at First Berlin Equity Research HAVE recently also their price target for die Sirona Biochem share to 0.98 CAD, was around 0.67 euros and THEREFORE Einem profit potential of over 400 per cent Equivalent. And this could only be the beginning, because die analysts cave envisaged licensing deal with HER new target price not yet considered